PCOS and Fertility: A Complete Guide to Getting Pregnant with Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS) is one of the most common hormonal conditions affecting women of reproductive age in Hong Kong and throughout Asia. It is also one of the most common causes of ovulatory infertility worldwide. Yet despite its prevalence and its profound impact on fertility, PCOS remains widely misunderstood — and many women with PCOS go on to conceive naturally or with minimal intervention when they receive the right guidance. This comprehensive guide covers the science of PCOS, its effects on fertility, and the evidence-based strategies — including supplements and sperm-friendly lubricants from Conceive Plus — that support conception.

What Is PCOS and How Common Is It in Hong Kong?

PCOS is a complex endocrine disorder characterised by a combination of irregular or absent ovulation (oligo- or anovulation), elevated androgens (hyperandrogenism, either clinical or biochemical), and polycystic ovarian morphology on ultrasound. Diagnosis requires at least two of these three features by the Rotterdam criteria, which are the internationally accepted diagnostic standard.

Globally, PCOS affects an estimated 5–15% of reproductive-age women, making it the most common endocrine disorder in this population. Studies examining PCOS prevalence in East Asian populations — including Hong Kong — consistently find rates in the 6–12% range, with some research suggesting that East Asian women with PCOS may present with less prominent clinical androgen signs (acne, hirsutism) but more significant insulin resistance than their Western counterparts, making diagnosis more challenging.

A 2021 study published in the Journal of Clinical Endocrinology and Metabolism found that Chinese women with PCOS had higher rates of insulin resistance and metabolic syndrome than age- and weight-matched women without PCOS, with implications for both fertility treatment response and long-term cardiovascular health. This metabolic phenotype is particularly relevant to the management of PCOS-related infertility.

How PCOS Affects Fertility

The primary fertility impact of PCOS is anovulation — the absence of regular ovulation. Without regular ovulation, conception cannot occur naturally, regardless of how well-timed intercourse might be. In women with PCOS, the dominant follicle often fails to reach full maturity and release an egg, instead remaining as a small cystic follicle that contributes to the characteristic "string of pearls" appearance on ovarian ultrasound.

The hormonal dysregulation underlying this ovulatory failure is multifactorial. Elevated LH levels — a hallmark of PCOS — create an unfavourable follicular environment that impairs egg maturation. Insulin resistance causes the ovaries to produce excess androgens (testosterone), which further disrupts follicle development. The resulting hormonal imbalance creates a self-perpetuating cycle that prevents the coordinated hormonal events required for ovulation.

Beyond anovulation, PCOS affects fertility through several additional mechanisms. Elevated androgens can impair egg quality and reduce fertilisation competence. Insulin resistance is associated with impaired endometrial receptivity, reducing implantation success even when fertilisation occurs. Women with PCOS also have higher rates of miscarriage compared to the general population — a risk attributable to poor egg quality, elevated LH at the time of ovulation, and suboptimal endometrial environment.

Despite these challenges, it is critically important to recognise that PCOS is a manageable condition. Most women with PCOS do conceive — approximately 70–80% achieve pregnancy within two years through various interventions, and many conceive naturally with lifestyle and supplement optimisation.

Inositol: The Leading Supplement for PCOS and Fertility

Myo-inositol has emerged as one of the most researched and clinically valuable supplements for women with PCOS. Inositol is a naturally occurring sugar alcohol that plays a central role in insulin signal transduction — directly addressing the insulin resistance that underlies much of PCOS pathophysiology.

A 2019 meta-analysis in Frontiers in Endocrinology encompassing 15 randomised controlled trials found that myo-inositol supplementation in women with PCOS produced statistically significant improvements in ovulation rate (resumption of spontaneous ovulation in approximately 70% of treated women versus 30% in placebo groups), menstrual cycle regularity, LH and androgens levels, and insulin resistance markers. Importantly, live birth rates were also significantly higher in the myo-inositol groups.

The most clinically validated form is myo-inositol combined with D-chiro-inositol at a 40:1 ratio — matching the ratio naturally found in human follicular fluid. This specific ratio has been validated in well-designed Italian and Chinese clinical trials as the most effective formulation for PCOS management.

Vitamin D and PCOS: Addressing a Common Deficiency in Hong Kong

Despite Hong Kong's subtropical climate, vitamin D deficiency is surprisingly prevalent — particularly among urban-dwelling women who spend most daylight hours indoors in office environments. Studies in Hong Kong populations have found vitamin D deficiency (serum 25-OH-D below 50 nmol/L) in 30–50% of women of reproductive age.

Among women with PCOS specifically, vitamin D deficiency is even more common and has more pronounced consequences. Vitamin D receptors are expressed throughout the female reproductive system — in the ovaries, endometrium, and hypothalamic-pituitary axis — and vitamin D deficiency directly impairs the hormonal signalling required for ovulation. A 2020 systematic review in Human Reproduction Update concluded that vitamin D supplementation in women with PCOS significantly improved ovulatory function, insulin sensitivity, and androgen levels.

The combination of inositol and vitamin D3 appears to be particularly synergistic in PCOS management, with several clinical trials demonstrating additive benefits for ovulation induction and metabolic parameters compared to either supplement alone. This combination forms the cornerstone of evidence-based supplement protocols for PCOS-related infertility.

PCOS and Cervical Mucus: Why a Fertility-Friendly Lubricant Matters

A less commonly discussed consequence of PCOS is its effect on cervical mucus quality. The hormonal dysregulation characteristic of PCOS — elevated androgens and disrupted oestrogen signalling — can significantly impair the quantity and quality of fertile cervical mucus produced around ovulation.

Fertile cervical mucus (the raw egg-white type) is biologically essential for sperm transport and survival. It creates channels that guide sperm toward the egg, provides a reservoir in which sperm survive for up to five days, and filters abnormal sperm. Without adequate fertile cervical mucus, sperm penetration of the cervix is impaired, even if ovulation occurs normally.

Women with PCOS also commonly experience irregular ovulation timing, making it difficult to predict exactly when fertile mucus should appear. When intercourse is timed around ovulation — particularly if using ovulation induction medications like letrozole or clomiphene, which can further dry cervical mucus — having a sperm-safe lubricant available is an important practical consideration.

Conceive Plus fertility lubricant is specifically formulated to address this need. Unlike standard lubricants sold in Hong Kong pharmacies, Conceive Plus is pH-balanced to match fertile cervical mucus, isotonic to human tissue, and uniquely enriched with calcium and magnesium ions that support sperm capacitation. Multiple studies have confirmed that standard lubricants significantly reduce sperm motility — a critical concern for women with PCOS who may already be navigating the challenges of irregular ovulation.

Lifestyle Strategies for PCOS Fertility: Evidence from Asian Research

Lifestyle modification is a first-line recommendation for PCOS management in all major guidelines, including those from the Chinese Society of Obstetrics and Gynecology. For women who are overweight or have elevated BMI, even a 5–10% weight reduction has been shown to restore ovulation in up to 55–60% of women — a dramatic effect achievable through dietary modification and exercise without pharmaceutical intervention.

The dietary approach with the strongest evidence for PCOS is a low-glycaemic index diet — reducing refined carbohydrates, white rice, and processed foods in favour of whole grains, vegetables, lean proteins, and healthy fats. This dietary pattern directly addresses insulin resistance, the metabolic driver of much of PCOS pathophysiology. A 2022 randomised controlled trial in Chinese women with PCOS found that a low-GI diet combined with myo-inositol supplementation produced significantly better ovulation outcomes than either intervention alone.

Regular moderate-intensity exercise — including the mind-body practices of yoga and tai chi that are culturally familiar in Hong Kong — has demonstrated meaningful benefits for PCOS, improving insulin sensitivity, reducing androgen levels, and promoting more regular ovulation. A systematic review found that 150 minutes of moderate exercise per week reduced testosterone levels and improved menstrual regularity in women with PCOS, with benefits comparable to metformin in some comparisons.

Medical Management of PCOS-Related Infertility in Hong Kong

For women with PCOS who do not ovulate spontaneously despite lifestyle and supplement optimisation, medical ovulation induction is highly effective. In Hong Kong, ovulation induction for PCOS typically begins with letrozole (an aromatase inhibitor) or clomiphene citrate as first-line oral therapy. Both are available through public Hospital Authority gynaecological services and private fertility clinics.

Letrozole has largely supplanted clomiphene as the preferred first-line agent for PCOS-related anovulatory infertility, following a landmark New England Journal of Medicine trial demonstrating higher cumulative live birth rates with letrozole compared to clomiphene in women with PCOS. Hong Kong's Hospital Authority fertility services and major private fertility centres including Hong Kong Reproductive Medicine (HKRM) and the Metropolis Healthcare Group routinely offer letrozole-based ovulation induction protocols.

For women who do not respond to oral ovulation induction, injectable gonadotrophins (FSH) with monitoring, laparoscopic ovarian drilling, or IVF may be indicated. IVF outcomes in women with PCOS are generally good — the high antral follicle count that is characteristic of PCOS means strong response to ovarian stimulation — but careful protocol selection is required to minimise the risk of ovarian hyperstimulation syndrome (OHSS).

FAQ: PCOS and Fertility